UBS ASSET MANAGEMENT AMERICAS INC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$7,288,544
-2.8%
406,047
-1.3%
0.00%
-25.0%
Q2 2023$7,502,1120.0%411,3000.0%0.00%0.0%
Q1 2023$7,502,112
-9.7%
411,300
+2.4%
0.00%0.0%
Q4 2022$8,308,583
-99.9%
401,769
-10.1%
0.00%
-42.9%
Q3 2022$11,686,561,000
+2.4%
446,734
-0.8%
0.01%
+16.7%
Q2 2022$11,417,063,000
+15.3%
450,555
+43.6%
0.01%
+50.0%
Q1 2022$9,904,729,000
+1.5%
313,838
+30.1%
0.00%0.0%
Q4 2021$9,761,808,000
+573.3%
241,211
+480.2%
0.00%
+300.0%
Q3 2021$1,449,790,000
+42.6%
41,577
+12.3%
0.00%
Q2 2021$1,016,568,000
+8.4%
37,020
+10.9%
0.00%
Q1 2021$937,479,000
-4.2%
33,386
-11.5%
0.00%
Q4 2020$979,082,000
+150.5%
37,715
+65.4%
0.00%
Q3 2020$390,792,000
-48.7%
22,800
-26.0%
0.00%
Q2 2020$762,363,000
+18.5%
30,815
-26.0%
0.00%
-100.0%
Q1 2018$643,107,00041,6520.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders